Law360, New York (November 5, 2012, 5:11 PM EST) -- A New York federal jury hit Novartis Pharmaceuticals Corp. with a $10.5 million verdict Friday in a suit brought by a woman whose jaw deteriorated after she took the bone drug Zometa, snapping a string of victories for the company in multidistrict litigation over the drug.
Plaintiff Barbara Davids won $450,000 in compensatory damages and $10 million in punitive damages, John Vecchione of Valad & Vecchione PLLC told Law360 on Monday.
The jury found Novartis failed to warn Davids that Zometa could cause osternecrosis of the...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.